These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38726812)

  • 1. Sarcoma incidence worldwide: regional differences in histology and molecular subtypes.
    Lee MJ; Chen TW
    Curr Opin Oncol; 2024 Jul; 36(4):276-281. PubMed ID: 38726812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soft tissue sarcoma incidences and clinical characteristics are significantly different in France and Taiwan.
    Chen TW; Chiang RC; Le Cesne A; Hsieh YC; Italiano A; Yang YW; Penel N; Lee WC; Bompas E; Valentin T; Anract P; Firmin N; Duffaud F; Cheng AL; Ducimetiere F; Chan KA; Blay JY
    Cancer; 2022 Sep; 128(18):3360-3369. PubMed ID: 35796499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nationwide incidence of sarcomas and connective tissue tumors of intermediate malignancy over four years using an expert pathology review network.
    de Pinieux G; Karanian M; Le Loarer F; Le Guellec S; Chabaud S; Terrier P; Bouvier C; Batistella M; Neuville A; Robin YM; Emile JF; Moreau A; Larousserie F; Leroux A; Stock N; Lae M; Collin F; Weinbreck N; Aubert S; Mishellany F; Charon-Barra C; Croce S; Doucet L; Quintin-Rouet I; Chateau MC; Bazille C; Valo I; Chetaille B; Ortonne N; Brouchet A; Rochaix P; Demuret A; Ghnassia JP; Mescam L; Macagno N; Birtwisle-Peyrottes I; Delfour C; Angot E; Pommepuy I; Ranchere D; Chemin-Airiau C; Jean-Denis M; Fayet Y; Courrèges JB; Mesli N; Berchoud J; Toulmonde M; Italiano A; Le Cesne A; Penel N; Ducimetiere F; Gouin F; Coindre JM; Blay JY;
    PLoS One; 2021; 16(2):e0246958. PubMed ID: 33630918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidences of Primary Soft Tissue Sarcoma Diagnosed on Extremities and Trunk Wall: A Population-Based Study in Taiwan.
    Hung GY; Yen CC; Horng JL; Liu CY; Chen WM; Chen TH; Liu CL
    Medicine (Baltimore); 2015 Oct; 94(41):e1696. PubMed ID: 26469906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ETIOSARC study : environmental aetiology of sarcomas from a French prospective multicentric population-based case-control study-study protocol.
    Lacourt A; Amadéo B; Gramond C; Marrer E; Plouvier S; Baldi I; Blay JY; Coindre JM; de Pinieux G; Gouin F; Italiano A; Le Cesne A; Le Loarer F; Monnereau A; Pellegrin I; Penel N; Ray-Coquard I; Toulmonde M; Ducimetière F; Mathoulin-Pélissier S;
    BMJ Open; 2019 Jun; 9(6):e030013. PubMed ID: 31217320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sarcomas other than Kaposi sarcoma occurring in immunodeficiency: interpretations from a systematic literature review.
    Bhatia K; Shiels MS; Berg A; Engels EA
    Curr Opin Oncol; 2012 Sep; 24(5):537-46. PubMed ID: 22729152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TERT promoter hotspot mutations are recurrent in myxoid liposarcomas but rare in other soft tissue sarcoma entities.
    Koelsche C; Renner M; Hartmann W; Brandt R; Lehner B; Waldburger N; Alldinger I; Schmitt T; Egerer G; Penzel R; Wardelmann E; Schirmacher P; von Deimling A; Mechtersheimer G
    J Exp Clin Cancer Res; 2014 Apr; 33(1):33. PubMed ID: 24726063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MET gene copy number alterations and expression of MET and hepatocyte growth factor are potential biomarkers in angiosarcomas and undifferentiated pleomorphic sarcomas.
    Schmitz K; Koeppen H; Binot E; Fassunke J; Künstlinger H; Ihle MA; Heydt C; Wardelmann E; Büttner R; Merkelbach-Bruse S; Rüschoff J; Schildhaus HU
    PLoS One; 2015; 10(4):e0120079. PubMed ID: 25844809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and time trends of sarcoma (2000-2013): results from the French network of cancer registries (FRANCIM).
    Amadeo B; Penel N; Coindre JM; Ray-Coquard I; Ligier K; Delafosse P; Bouvier AM; Plouvier S; Gallet J; Lacourt A; Coureau G; Monnereau A; Mathoulin-Pélissier S; Desandes E
    BMC Cancer; 2020 Mar; 20(1):190. PubMed ID: 32138705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Incidence rate, epidemiology of sarcoma and molecular biology. Preliminary results from EMS study in the Rhône-Alpes region].
    Ducimetière F; Lurkin A; Ranchère-Vince D; Decouvelaere AV; Isaac S; Claret-Tournier C; Suignard Y; Salameire D; Cellier D; Alberti L; Bringuier PP; Blay JY; Ray-Coquard I
    Bull Cancer; 2010 Jun; 97(6):629-41. PubMed ID: 20504759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and Pathologic Characterization of 94 Radiation-Associated Sarcomas: Our Institutional Experience.
    Kao EY; McEwen AE; Aden JK; Schaub SK; Ricciotti RW; Mantilla JG
    Int J Surg Pathol; 2023 Aug; 31(5):532-547. PubMed ID: 35695212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of the Incidence and Geographic Distribution of Bone and Soft Tissue Sarcomas in Canada: A National Population-Based Study.
    Alkazemi B; Ghazawi FM; Lagacé F; Nechaev V; Zubarev A; Litvinov IV
    Curr Oncol; 2023 Jun; 30(6):5631-5651. PubMed ID: 37366907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overall and net survival of patients with sarcoma between 2005 and 2010: Results from the French Network of Cancer Registries (FRANCIM).
    Amadeo B; Penel N; Coindre JM; Ray-Coquard I; Plouvier S; Delafosse P; Bouvier AM; Gallet J; Lacourt A; Galvin A; Coureau G; Monnereau A; Blay JY; Desandes E; Mathoulin-Pélissier S;
    Cancer; 2022 Jul; 128(13):2483-2492. PubMed ID: 35385134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telomere lengths of translocation-associated and nontranslocation-associated sarcomas differ dramatically.
    Montgomery E; Argani P; Hicks JL; DeMarzo AM; Meeker AK
    Am J Pathol; 2004 May; 164(5):1523-9. PubMed ID: 15111298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MDM2 gene amplification and transcript levels in human sarcomas: relationship to TP53 gene status.
    Flørenes VA; Maelandsmo GM; Forus A; Andreassen A; Myklebost O; Fodstad O
    J Natl Cancer Inst; 1994 Sep; 86(17):1297-302. PubMed ID: 8064888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutational and expressional analyses of NRF2 and KEAP1 in sarcomas.
    Je EM; An CH; Yoo NJ; Lee SH
    Tumori; 2012; 98(4):510-5. PubMed ID: 23052169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutational analysis of PIK3CA, JAK2, BRAF, FOXL2, IDH1, AKT1 and EZH2 oncogenes in sarcomas.
    Je EM; An CH; Yoo NJ; Lee SH
    APMIS; 2012 Aug; 120(8):635-9. PubMed ID: 22779686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strengthening health data on a rare and heterogeneous disease: sarcoma incidence and histological subtypes in Germany.
    Ressing M; Wardelmann E; Hohenberger P; Jakob J; Kasper B; Emrich K; Eberle A; Blettner M; Zeissig SR
    BMC Public Health; 2018 Feb; 18(1):235. PubMed ID: 29433465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Programmed Death Ligand 1 (PD-L1) Expression in Malignant Mesenchymal Tumors.
    Kösemehmetoğlu K; Özoğul E; Babaoğlu B; Tezel GG; Gedikoğlu G
    Turk Patoloji Derg; 2017; 1(1):192-197. PubMed ID: 28832074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NF1 deletion generates multiple subtypes of soft-tissue sarcoma that respond to MEK inhibition.
    Dodd RD; Mito JK; Eward WC; Chitalia R; Sachdeva M; Ma Y; Barretina J; Dodd L; Kirsch DG
    Mol Cancer Ther; 2013 Sep; 12(9):1906-17. PubMed ID: 23858101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.